期刊
NEUROBIOLOGY OF AGING
卷 32, 期 2, 页码 327-335出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2009.02.002
关键词
Dopaminergic treatment; Parkinson's disease; Response monitoring; De novo Parkinson's disease; Aging
资金
- Deutsche Forschungsgemeinschaft (DFG) [FA 211/16-1, FA 211/16-3]
- Ruhr University Bochum [AZ-F479-2005]
We examined effects of short-term and long-term dopaminergic medication in Parkinson's disease on conflict monitoring or response selection processes. These processes were examined using event-related potentials (ERPs), while subjects performed a stimulus-response (S-R) compatibility task. An extended sample of young and elderly controls, Parkinson's disease patients with a medication history (PDs) and initially diagnosed, drug-naive de novo PD patients (de novo PDs) were enrolled. Both PD groups were measured twice (on and off-medication or before and 8 weeks after medication onset). The results show that dopaminergic intervention selectively reduced the pathologically enhanced response selection in compatible S-R relations. This medication effect was already evident after short-term treatment, not differing from long-term treatment and performance in elderly controls. Contrary, age-related attenuations of the N2 in incompatible S-R relations, probably reflecting impaired conflict processing or response control, are unaffected by medication. The results suggest that compatible and incompatible S-R relations demand different neuronal mechanisms within the basal ganglia, as only the former are affected by agonizing the dopaminergic system. (C) 2009 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据